Top compounds associated with response to IRF7


Feature Type Standardized
Nominal ANOVA
mRNA Bortezomib gCSI pan-cancer AAC -0.048 0.4
mRNA SB-431542 CTRPv2 pan-cancer AAC 0.031 0.4
mRNA JQ-1:carboplatin (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.026 0.4
mRNA tacedinaline CTRPv2 pan-cancer AAC -0.03 0.4
mRNA RO-3306 GDSC1000 pan-cancer AAC 0.029 0.4
mRNA TG-101348 GDSC1000 pan-cancer AAC -0.023 0.4
mRNA JW-480 CTRPv2 pan-cancer AAC -0.03 0.4
mRNA BRD-A02303741:carboplatin (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.03 0.4
mRNA necrosulfonamide CTRPv2 pan-cancer AAC 0.03 0.4
mRNA Nilotinib GDSC1000 pan-cancer AAC -0.03 0.4
Download CSV